Literature DB >> 25505050

Biomarkers and pharmaceutical strategies in steroid-induced osteonecrosis of the femoral head: a literature review.

Xinyu Qi1, Yirong Zeng2.   

Abstract

The underlying pathology of steroid-induced osteonecrosis of the femoral head (ONFH) is unclear but is known to be multifactorial. It is therefore difficult to find a single predictive biomarker for this disease, and multiple biomarkers are likely to contribute to ONFH progression. Investigation of protein-protein interactions is vital in order to elucidate fully the pathogenesis of this disease, and provide new treatment strategies. This review article discusses the known biomarkers and current treatment strategies for ONFH.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Osteonecrosis; avascular necrosis; biomarker; femoral head; treatment

Mesh：

Substances：

Year:  2014        PMID： 25505050     DOI： 10.1177/0300060514554724

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


  8 in total

Review 1.  Emerging roles of MicroRNAs in osteonecrosis of the femoral head.

Authors:  Zheng Li; Bo Yang; Xisheng Weng; Gary Tse; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2017-11-12       Impact factor: 6.831

Review 2.  Steroid-induced ischemic bone necrosis of femoral head: Treatment strategies.

Authors:  Bin Wu; Zhong Dong; Shuyuan Li; Hongmei Song
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

3.  Attenuated serum adiponectin levels are associated with disease severity in patients with non-traumatic osteonecrosis of the femoral head.

Authors:  Yong-Bin Yue; Xin Liu; Biao-Fang Wei
Journal:  J Pain Res       Date:  2017-10-03       Impact factor: 3.133

4.  Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head-A first multicentre, randomised, double-blind, placebo-controlled clinical trial.

Authors:  Zi-Rong Li; Li-Ming Cheng; Kun-Zheng Wang; Nan-Ping Yang; Shu-Hua Yang; Wei He; Yi-Sheng Wang; Zhong-Ming Wang; Pei Yang; Xian-Zhe Liu; Yue-Zhong Luo; Wei Sun; Hai-Tao Wang; Li-Zhen Zheng; Xin-Luan Wang; Ling Qin
Journal:  J Orthop Translat       Date:  2017-12-14       Impact factor: 5.191

5.  Treatment of steroid-induced osteonecrosis of the femoral head using porous Se@SiO2 nanocomposites to suppress reactive oxygen species.

Authors:  Guoying Deng; Kerun Niu; Feng Zhou; Buxiao Li; Yingjie Kang; Xijian Liu; Junqing Hu; Bo Li; Qiugen Wang; Chengqing Yi; Qian Wang
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

6.  Exploring the Risk Factors for the Misdiagnosis of Osteonecrosis of Femoral Head: A Case-Control Study.

Authors:  Wen-Long Li; Biao Tan; Zhao-Xu Jia; Bo Dong; Ze-Qing Huang; Rui-Zheng Zhu; Wei Zhao; Huan-Huan Gao; Rong-Tian Wang; Wei-Heng Chen
Journal:  Orthop Surg       Date:  2020-10-16       Impact factor: 2.071

7.  Osteogenesis-Related Long Noncoding RNA GAS5 as a Novel Biomarker for Osteonecrosis of Femoral Head.

Authors:  Guanzhi Liu; Sen Luo; Yutian Lei; Ming Jiao; Ruomu Cao; Huanshuai Guan; Run Tian; Kunzheng Wang; Pei Yang
Journal:  Front Cell Dev Biol       Date:  2022-03-22

8.  Prevalence of Nontraumatic Osteonecrosis of the Femoral Head and its Associated Risk Factors in the Chinese Population: Results from a Nationally Representative Survey.

Authors:  De-Wei Zhao; Mang Yu; Kai Hu; Wei Wang; Lei Yang; Ben-Jie Wang; Xiao-Hong Gao; Yong-Ming Guo; Yong-Qing Xu; Yu-Shan Wei; Si-Miao Tian; Fan Yang; Nan Wang; Shi-Bo Huang; Hui Xie; Xiao-Wei Wei; Hai-Shen Jiang; Yu-Qiang Zang; Jun Ai; Yuan-Liang Chen; Guang-Hua Lei; Yu-Jin Li; Geng Tian; Zong-Sheng Li; Yong Cao; Li Ma
Journal:  Chin Med J (Engl)       Date:  2015-11-05       Impact factor: 2.628
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.